243070.KQ
Huons Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 20,950.00
+0.24%Year over year
Reported trailing growth
- Revenue
- +2.1%
- EBITDA
- -57.7%
- EBIT
- -52.1%
- EPS
- -45.7%
- Free cash flow
- +235.4%
- Operating cash flow
- +8.7%
Forward estimates
Based on analyst estimates
- Revenue
- -24.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +8.0%
- EBITDA
- +6.5%
- EBIT
- +3.7%
- Net income
- +23.9%
- EPS
- +24.4%
- Free cash flow
- +83.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026